Panbela Therapeutics Announced Abstract For SBP-101 Accepted For Poster Presentation At American Association For Cancer Research
Panbela Therapeutics Inc Ordinary Shares 0.00% Pre
Panbela Therapeutics Inc Ordinary Shares PBLA |
| 0.00% Pre |
Poster Presentation
- Title: Ivospemin/doxorubicin combination modulates polyamine metabolism to improve survival in murine ovarian cancer models
- Session Category: Experimental and Molecular Therapeutics
Session Title: Novel Antitumor Agents 6
Session Date and Time: Wednesday, April 10, 9:00-12:30
Abstract #: 7154 - Additional meeting information can be found on the AACR website: https://www.aacr.org/meeting/aacr-annual-meeting-2024/abstracts/
- The abstract and poster will also be available on the Company's website at https://panbela.com/events-presentations/ once the information has been released by AACR.